ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

Clinical trial NCT06656494 · RECRUITING

Trial details

NCT number: NCT06656494
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia Myelodysplastic Syndromes (MDS)

Start date: 2024-12-18
Primary completion: 2027-06-01
Enrollment: 266

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.